# Neoadjuvant SBRT in Localized Advanced HNSCC

> **NCT06306846** · PHASE2 · RECRUITING · sponsor: **Jiang Feng** · enrollment: 81 (estimated)

## Conditions studied

- Head and Neck Squamous Carcinoma

## Interventions

- **RADIATION:** SBRT+immunochemotherpy
- **DRUG:** Immunochemotherapy
- **DRUG:** cetuximab+immunochemotharpy

## Key facts

- **NCT ID:** NCT06306846
- **Lead sponsor:** Jiang Feng
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-10-01
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 81 (ESTIMATED)
- **Last updated:** 2024-03-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06306846

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06306846, "Neoadjuvant SBRT in Localized Advanced HNSCC". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06306846. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*